Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,129 | -788 | -3,842 | -3,850 | -2,755 |
| Depreciation Amortization | 203 | 100 | 367 | 270 | 175 |
| Accounts receivable | -725 | N/A | -66 | N/A | N/A |
| Accounts payable and accrued liabilities | 69 | 35 | 602 | 778 | 659 |
| Other Working Capital | -459 | 269 | -183 | 824 | 598 |
| Other Operating Activity | 3,301 | -15 | -786 | -707 | -611 |
| Operating Cash Flow | $-1,740 | $-399 | $-3,908 | $-2,685 | $-1,934 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,650 | 400 | 4,350 | 2,200 | 1,500 |
| Debt Repayment | N/A | N/A | -2,573 | -1,719 | -1,220 |
| Other Financing Activity | 14 | 3 | 2 | 2 | 2 |
| Financing Cash Flow | $1,664 | $403 | $1,779 | $483 | $282 |
| Beginning Cash Position | 91 | 91 | 2,220 | 2,220 | 2,220 |
| End Cash Position | 15 | 95 | 91 | 18 | 568 |
| Net Cash Flow | $-76 | $4 | $-2,129 | $-2,202 | $-1,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,740 | -399 | -3,908 | -2,685 | -1,934 |
| Free Cash Flow | -1,740 | -399 | -3,908 | -2,685 | -1,934 |